Saroja Pharma Industries India Q4 Results
- BSE: -
- NSE: SAROJA
- ISIN: INE0PCL01011
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
33.95
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Thu 16 Apr, 2026 | 15:40:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Saroja Pharma Industries India Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | - | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 33.41 | - | N/A |
| Depreciation/ Amortization | 0.06 | - | N/A |
| Operating Income | 1.59 | - | N/A |
| Net Income | 0.70 | - | N/A |
| Net Income Before Taxes | 0.98 | - | N/A |
| Other Operating Expenses Total | 0.51 | - | N/A |
| Total Revenue | 35.00 | - | N/A |
| Selling/ General/ Admin Expenses Total | 0.69 | - | N/A |
| Diluted Normalized EPS | 1.75 | - | N/A |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.